{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:31:08Z","timestamp":1778081468161,"version":"3.51.4"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1097\/ftd.0000000000000217","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T10:48:54Z","timestamp":1430304534000},"page":"783-791","source":"Crossref","is-referenced-by-count":6,"title":["Therapeutic Drug Monitoring of Pentobarbital"],"prefix":"10.1097","volume":"37","author":[{"given":"Robert M.","family":"Humble","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Ehlers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany L.","family":"Pakalniskis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cory","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denny","family":"Drees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Kulhavy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Krasowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/PCC.0b013e318271c3b2","article-title":". High-dose barbiturates for refractory intracranial hypertension in children with severe traumatic brain injury.","volume":"14","author":"Mellion","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R2-13-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3171\/2013.3.PEDS12196","article-title":"N, deSouza RM, Sikorski C, et al.. Role of barbiturate coma in the management of focally induced, severe cerebral edema in children.","volume":"12","year":"2013","journal-title":"J Neurosurg Pediatr"},{"key":"R3-13-20210129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/TA.0b013e3181de74c7","article-title":". Pentobarbital coma for refractory intra-cranial hypertension after severe traumatic brain injury: mortality predictions and one-year outcomes in 55 patients.","volume":"69","author":"Marshall","year":"2010","journal-title":"J Trauma"},{"key":"R4-13-20210129","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pediatrneurol.2008.01.001","article-title":"Treatment of refractory status epilepticus: literature review and a proposed protocol.","volume":"38","author":"Abend","year":"2008","journal-title":"Pediatr Neurol"},{"key":"R5-13-20210129","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01376517-200310000-00003","article-title":"Pentobarbital sodium coma for refractory intracranial hypertension.","volume":"35","author":"Censullo","year":"2003","journal-title":"J Neurosci Nurs"},{"key":"R6-13-20210129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0887-8994(95)00114-U","article-title":". Pentobarbital therapy for status epilepticus in children: timing of tapering.","volume":"13","author":"Kinoshita","year":"1995","journal-title":"Pediatr Neurol"},{"key":"R7-13-20210129","first-page":"CD000033","article-title":"Barbiturates for acute traumatic brain injury.","volume":"12","author":"Roberts","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-13-20210129","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00044067-200510000-00009","article-title":"Refractory increased intracranial pressure in severe traumatic brain injury: barbiturate coma and bispectral index monitoring.","volume":"16","author":"Bader","year":"2005","journal-title":"AACN Clin Issues"},{"key":"R9-13-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00007691-198606000-00003","article-title":"Monitoring of pentobarbital plasma levels in critical care patients suffering from increased intracranial pressure.","volume":"8","author":"Heinemeyer","year":"1986","journal-title":"Ther Drug Monit"},{"key":"R10-13-20210129","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1515\/CCLM.2008.335","article-title":". Drugs and brain death diagnostics: determination of drugs capable of inducing EEG zero line.","volume":"46","author":"Meinitzer","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"R11-13-20210129","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJM200104193441606","article-title":"The diagnosis of brain death.","volume":"344","author":"Wijdicks","year":"2001","journal-title":"N Engl J Med"},{"key":"R12-13-20210129","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00003246-200002000-00070","article-title":"Drugs and brain death testing.","volume":"28","author":"Wenck","year":"2000","journal-title":"Crit Care Med"},{"key":"R13-13-20210129","first-page":"404","article-title":". Therapeutic drug monitoring: measurements of antiepileptic and barbiturate drug levels in blood by gas chromatography with nitrogenselective detector.","volume":"6","author":"Lehane","year":"1976","journal-title":"Ann Clin Lab Sci"},{"key":"R14-13-20210129","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jat\/7.4.178","article-title":"Determination of pentobarbital and certain other barbiturates by capillary gas-liquid chromatography.","volume":"7","author":"Wallace","year":"1983","journal-title":"J Anal Toxicol"},{"key":"R15-13-20210129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-60761-459-3_7","article-title":"Quantitation of amobarbital, butalbital, pentobarbital, phenobarbital, and secobarbital in urine, serum, and plasma using gas chromatography-mass spectrometry (GC-MS).","volume":"603","author":"Johnson","year":"2010","journal-title":"Methods Mol Biol"},{"key":"R16-13-20210129","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/clinchem\/29.6.1097","article-title":"Reversed-phase liquid-chromatographic simultaneous analysis for thiopental and pentobarbital in serum.","volume":"29","author":"Kelner","year":"1983","journal-title":"Clin Chem"},{"key":"R17-13-20210129","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/(SICI)1097-0231(19980715)12:13<890::AID-RCM251>3.0.CO;2-X","article-title":". Supercritical fluid extraction and negative ion electrospray liquid chromatography tandem mass spectrometry analysis of phenobarbital, butalbital, pentobarbital and thiopental in human serum.","volume":"12","author":"Spell","year":"1998","journal-title":"Rapid Commun Mass Spectrom"},{"key":"R18-13-20210129","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007691-199910000-00012","article-title":". Comparison of the serum barbiturate fluorescence polarization immunoassay by the COBAS INTEGRA to a GCMS method.","volume":"21","author":"Cannon","year":"1999","journal-title":"Ther Drug Monit"},{"key":"R19-13-20210129","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00007691-198208000-00012","article-title":"Rapid estimation of plasma pentobarbital levels by an enzyme immunoassay for barbiturates (EMIT).","volume":"4","author":"Wellington","year":"1982","journal-title":"Ther Drug Monit"},{"key":"R20-13-20210129","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00007691-198312000-00014","article-title":". Pentobarbital quantitation using EMIT serum barbiturate assay reagents: application to monitoring of high-dose pentobarbital therapy.","volume":"5","author":"Pape","year":"1983","journal-title":"Ther Drug Monit"},{"key":"R21-13-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/clinchem\/30.2.307","article-title":"Rapid quantification of pentobarbital in serum by fluorescence polarization immunoassay.","volume":"30","author":"Li","year":"1984","journal-title":"Clin Chem"},{"key":"R22-13-20210129","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/clinchem\/37.10.1774","article-title":". Pentobarbital quantification in the presence of phenobarbital by fluorescence polarization immunoassay.","volume":"37","author":"Earl","year":"1991","journal-title":"Clin Chem"},{"key":"R23-13-20210129","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1373\/clinchem.2008.118638","article-title":". Chemoinformatic methods for predicting interference in drug of abusetoxicology immunoassays.","volume":"55","author":"Krasowski","year":"2009","journal-title":"Clin Chem"},{"key":"R24-13-20210129","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1542\/pir.18-8-260","article-title":"Barbiturates.","volume":"18","author":"Coupey","year":"1997","journal-title":"Pediatr Rev"},{"key":"R25-13-20210129","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/FTD.0b013e31819c1b83","article-title":". Molecular similarity methods for predicting cross-reactivity with therapeutic drug monitoring immunoassays.","volume":"31","author":"Krasowski","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R26-13-20210129","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1212\/WNL.38.3.395","article-title":"Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients.","volume":"38","author":"Lowenstein","year":"1988","journal-title":"Neurology"},{"key":"R27-13-20210129","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1476-5381.1972.tb07292.x","article-title":"Metabolism of amylobarbitone in patients with chronic liver disease.","volume":"44","author":"Mawer","year":"1972","journal-title":"Br J Pharmacol"},{"key":"R28-13-20210129","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1476-5381.1970.tb10364.x","article-title":". The kinetics of amylobarbitone metabolism in healthy men and women.","volume":"39","author":"Balasubramaniam","year":"1970","journal-title":"Br J Pharmacol"},{"key":"R30-13-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jat\/27.3.145","article-title":". Distribution of butalbital in postmortem tissues and fluids from non-overdose cases.","volume":"27","author":"Lewis","year":"2003","journal-title":"J Anal Toxicol"},{"key":"R31-13-20210129","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/bja\/48.7.643","article-title":"Pharmacokinetics of methohexitone following intravenous infusion in humans.","volume":"48","author":"Breimer","year":"1976","journal-title":"Br J Anaesth"},{"key":"R32-13-20210129","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00000542-198505000-00004","article-title":". Methohexital plasma concentrations in children following rectal administration.","volume":"62","author":"Liu","year":"1985","journal-title":"Anesthesiology"},{"key":"R33-13-20210129","first-page":"33","article-title":". Rectal absorption and disposition of secobarbital in epileptic children.","volume":"2","author":"Levine","year":"1982","journal-title":"Pediatr Pharmacol (New York)"},{"key":"R34-13-20210129","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/j.1552-4604.1979.tb01648.x","article-title":". Overdosage with pentobarbital and secobarbital: assessment of factors related to outcome.","volume":"19","author":"Greenblatt","year":"1979","journal-title":"J Clin Pharmacol"},{"key":"R35-13-20210129","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1399-6576.1983.tb01949.x","article-title":"Influence of moderate alcohol intake on wakening plasma thiopental concentration.","volume":"27","author":"Loft","year":"1983","journal-title":"Acta Anaesthesiol Scand"},{"key":"R36-13-20210129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF01059279","article-title":". Pharmacodynamic modeling of thiopental anesthesia.","volume":"12","author":"Stanski","year":"1984","journal-title":"J Pharmacokinet Biopharm"},{"key":"R38-13-20210129","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/FTD.0b013e31825a4d9c","article-title":". Minimization of the preanalytical error in pharmacokinetic analyses and therapeutic drug monitoring: focus on IV drug administration.","volume":"34","author":"Kontny","year":"2012","journal-title":"Ther Drug Monit"},{"key":"R39-13-20210129","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/FTD.0b013e31823aa8ab","article-title":". Minimization of the preanalytical error in plasma samples for pharmacokinetic analyses and therapeutic drug monitoring-using doxorubicin as an example.","volume":"33","author":"Kontny","year":"2011","journal-title":"Ther Drug Monit"},{"key":"R40-13-20210129","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archinte.163.8.893","article-title":". Linking laboratory and pharmacy: opportunities for reducing errors and improving care.","volume":"163","author":"Schiff","year":"2003","journal-title":"Arch Intern Med"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:29:39Z","timestamp":1620952179000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201512000-00013"}},"subtitle":["Experience at an Academic Medical Center"],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000217","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}